Ribomic Inc.
(株)リボミック
2026/08/25 Updated
Market Cap:
$29.1M (¥4.6B)
Stock Price:
$0.51 (¥82)
Exchange Rate: 1 USD = ¥159.24
Supplementary Explanation on Study Design and Safety in the Domestic Phase III Clinical Trial of Treatment for Achondroplasia (umedaptanib pegol)
Ｇ－リボミック
Company overview · Stock price · Financial data · All IR
